Virtual biotech company puts thousands of AI scientist agents to work on drug discovery

A virtual biotechnology firm is deploying thousands of autonomous AI scientist agents to conduct drug discovery research. By automating experimental workflows, the project aims to accelerate the identification of new therapeutic candidates. This approach reflects a broader industry shift toward using large-scale computational systems to handle repetitive laboratory tasks and complex data analysis in pharmaceutical development.